TY - JOUR T1 - Causes and predictive factors of mortality in a cohort of patients with hepatitis C virus-related cryoglobulinemic vasculitis treated with antiviral therapy JF - J Rheumatol Y1 - 2010 A1 - Landau, D.A. A1 - Scerra, S. A1 - Sene, D. A1 - Resche-Rigon, M. A1 - Saadoun, D. A1 - Cacoub, P. KW - Aged KW - Aged,80 and over KW - analysis KW - Antiviral Agents KW - Carcinoma KW - Cause of Death KW - Central Nervous System KW - Cohort Studies KW - complications KW - Cryoglobulinemia KW - Death KW - Disease KW - drug therapy KW - Female KW - France KW - HCV KW - Hepacivirus KW - hepatitis KW - Hepatitis C KW - hepatitis C virus KW - history KW - Humans KW - Infection KW - interferon KW - Interferon Alfa-2a KW - Interferon-alpha KW - Kaplan-Meier Estimate KW - Liver KW - Male KW - methods KW - Middle Aged KW - Morbidity KW - Mortality KW - Paris KW - Patients KW - peginterferon KW - Polyethylene Glycols KW - Predictive Value of Tests KW - Prognosis KW - Proteins KW - Recombinant Proteins KW - Regression Analysis KW - Renal KW - Renal Insufficiency KW - Retrospective Studies KW - Ribavirin KW - Risk KW - Severity of Illness Index KW - Survivors KW - therapeutic use KW - therapy KW - treatment KW - ulcer KW - Vasculitis KW - Viral Load KW - virology VL - 37 SP - 615-621 IS - 3 ER -